Literature DB >> 1705568

Decreased content and surface expression of alpha-granule membrane protein GMP-140 in one of two types of platelet alpha delta storage pool deficiency.

B Lages1, S J Shattil, D F Bainton, H J Weiss.   

Abstract

To determine whether alpha-granule membranes are present in platelets of patients with storage pool deficiencies of both alpha and dense granules (alpha delta-SPD), we examined the content and surface expression of the alpha-granule membrane protein GMP-140 in one patient (J.C.) with a severe alpha-granule deficiency and in three members of a family (family C) with milder alpha-granule deficiencies. Surface expression of GMP-140 in stimulated platelets, assessed by flow cytometric measurements of the binding of two anti-GMP-140 monoclonal antibodies, was 24-38% of normal values in platelets from patient J.C., vs. 60-95% of normal values in family C. Total platelet content of GMP-140, determined in platelet lysates by antigen-capture ELISA, was 49% of normal in patient J.C., but normal in the members of family C. Platelets of patient J.C. were found to be heterogeneous with respect to GMP-140 content and surface expression by both flow cytometry and immunogold electron microscopy. Approximately 80% of her platelets expressed little or no GMP-140 after stimulation, whereas the remaining 20% expressed normal amounts of GMP-140 and showed extensive immunogold labeling of typical alpha-granules and clear vacuoles. No such heterogeneity was found in platelets from family C. These findings in the severe alpha delta-SPD patient are in clear contrast to the observations of normal GMP-140 content in the three other alpha delta-SPD patients, and in patients with the gray platelet syndrome, reported previously by others. These results illustrate the phenotypic heterogeneity of alpha-granule deficiencies in human platelets, and suggest that a defect in granule formation in the megakaryocytes may account for the alpha-granule defect in at least one form of alpha delta-SPD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705568      PMCID: PMC329883          DOI: 10.1172/JCI115099

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.

Authors:  S J Shattil; J A Hoxie; M Cunningham; L F Brass
Journal:  J Biol Chem       Date:  1985-09-15       Impact factor: 5.157

2.  Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface.

Authors:  J P Rosa; J N George; D F Bainton; A T Nurden; J P Caen; R P McEver
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

3.  A familialdefect in platelet function associated with imapired release of adenosine diphosphate.

Authors:  H J Weiss; P A Chervenick; R Zalusky; A Factor
Journal:  N Engl J Med       Date:  1969-12-04       Impact factor: 91.245

4.  GMP-140 mediates adhesion of stimulated platelets to neutrophils.

Authors:  S A Hamburger; R P McEver
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

5.  Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules.

Authors:  P J Handagama; M A Shuman; D F Bainton
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes.

Authors:  E Larsen; A Celi; G E Gilbert; B C Furie; J K Erban; R Bonfanti; D D Wagner; B Furie
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

Review 7.  Platelet granule disorders.

Authors:  J G White
Journal:  Crit Rev Oncol Hematol       Date:  1986       Impact factor: 6.312

8.  Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules.

Authors:  H J Weiss; V T Turitto; H R Baumgartner
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

9.  Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry.

Authors:  S J Shattil; M Cunningham; J A Hoxie
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

10.  Viral membrane proteins acquire galactose in trans Golgi cisternae during intracellular transport.

Authors:  G Griffiths; R Brands; B Burke; D Louvard; G Warren
Journal:  J Cell Biol       Date:  1982-12       Impact factor: 10.539

View more
  3 in total

1.  Combined alpha-delta platelet storage pool deficiency is associated with mutations in GFI1B.

Authors:  Carlos R Ferreira; Dong Chen; Shirley M Abraham; David R Adams; Karen L Simon; May C Malicdan; Thomas C Markello; Meral Gunay-Aygun; William A Gahl
Journal:  Mol Genet Metab       Date:  2016-12-18       Impact factor: 4.797

2.  Hereditary leukemia due to rare RUNX1c splice variant (L472X) presents with eczematous phenotype.

Authors:  A Sorrell; C Espenschied; W Wang; J Weitzel; S Chu; P Parker; S Saldivar; R Bhatia
Journal:  Int J Clin Med       Date:  2012-12-01

3.  Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p.

Authors:  Meral Gunay-Aygun; Yifat Zivony-Elboum; Fatma Gumruk; Dan Geiger; Mualla Cetin; Morad Khayat; Robert Kleta; Nehama Kfir; Yair Anikster; Judith Chezar; Mauricio Arcos-Burgos; Adel Shalata; Horia Stanescu; Joseph Manaster; Mutlu Arat; Hailey Edwards; Andrew S Freiberg; P Suzanne Hart; Lauren C Riney; Katherine Patzel; Pranoot Tanpaiboon; Tom Markello; Marjan Huizing; Irina Maric; McDonald Horne; Beate E Kehrel; Kerstin Jurk; Nancy F Hansen; Praveen F Cherukuri; Marypat Jones; Pedro Cruz; Jim C Mullikin; Alan Nurden; James G White; William A Gahl; Tzippora Falik-Zaccai
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.